Scientists hunt for clues in blood and marrow to outsmart brain cancer
NCT ID NCT04657146
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study aims to understand how immune cells in the blood and bone marrow change over time in people with glioblastoma, a serious brain cancer. Researchers will collect samples from about 40 adults before and during standard treatment. The goal is to gather information that could lead to new immunotherapy treatments, but this study does not test any new drug or therapy itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.